These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 17719518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping.
    Streetman DS, Ellis RE, Nafziger AN, Leeder JS, Gaedigk A, Gotschall R, Kearns GL, Bertino JS.
    Clin Pharmacol Ther; 1999 Nov; 66(5):535-41. PubMed ID: 10579482
    [Abstract] [Full Text] [Related]

  • 6. Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms.
    Yu A, Kneller BM, Rettie AE, Haining RL.
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1291-300. PubMed ID: 12438554
    [Abstract] [Full Text] [Related]

  • 7. Dextromethorphan poisoning in an adolescent with genetic cytochrome P450 CYP2D6 deficiency.
    Baumann P, Vlatkovic D, Macciardi F.
    Therapie; 1997 Dec; 52(6):607-8. PubMed ID: 9734115
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application.
    Dickinson GL, Rezaee S, Proctor NJ, Lennard MS, Tucker GT, Rostami-Hodjegan A.
    J Clin Pharmacol; 2007 Feb; 47(2):175-86. PubMed ID: 17244768
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans.
    O'Mathúna B, Farré M, Rostami-Hodjegan A, Yang J, Cuyàs E, Torrens M, Pardo R, Abanades S, Maluf S, Tucker GT, de la Torre R.
    J Clin Psychopharmacol; 2008 Oct; 28(5):523-9. PubMed ID: 18794647
    [Abstract] [Full Text] [Related]

  • 12. [Dextromethorphane intoxication under co-medication with cytochrome P450-inhibitor fluoxetin: prolonged and accentuated signs of intoxication].
    Eichhorn M, Eich P.
    Psychiatr Prax; 2002 Sep; 29(6):321-2. PubMed ID: 12402964
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent.
    Lussenburg BM, Keizers PH, de Graaf C, Hidestrand M, Ingelman-Sundberg M, Vermeulen NP, Commandeur JN.
    Biochem Pharmacol; 2005 Oct 15; 70(8):1253-61. PubMed ID: 16135359
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic profile of dextromethorphan hydrobromide in a syrup formulation in children and adolescents.
    Guenin E, Armogida M, Riff D.
    Clin Drug Investig; 2014 Sep 15; 34(9):609-16. PubMed ID: 25027615
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment.
    Bozina N, Jovanović N, Lovrić M, Medved V.
    Ther Drug Monit; 2008 Dec 15; 30(6):748-51. PubMed ID: 18806696
    [Abstract] [Full Text] [Related]

  • 17. Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?
    Vandel P, Haffen E, Vandel S, Bonin B, Sechter D, Bizouard P, Dalery J.
    Therapie; 2000 Dec 15; 55(3):349-53. PubMed ID: 10967711
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.
    Preskorn S, Patroneva A, Silman H, Jiang Q, Isler JA, Burczynski ME, Ahmed S, Paul J, Nichols AI.
    J Clin Psychopharmacol; 2009 Feb 15; 29(1):39-43. PubMed ID: 19142106
    [Abstract] [Full Text] [Related]

  • 19. Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism.
    Keizers PH, Lussenburg BM, de Graaf C, Mentink LM, Vermeulen NP, Commandeur JN.
    Biochem Pharmacol; 2004 Dec 01; 68(11):2263-71. PubMed ID: 15498516
    [Abstract] [Full Text] [Related]

  • 20. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
    Rebsamen MC, Desmeules J, Daali Y, Chiappe A, Diemand A, Rey C, Chabert J, Dayer P, Hochstrasser D, Rossier MF.
    Pharmacogenomics J; 2009 Feb 01; 9(1):34-41. PubMed ID: 18591960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.